Siemens gets FDA nod for Artis icono angiography units
September 16, 2019 -- Siemens Healthineers has received U.S. Food and Drug Administration (FDA) clearance for its Artis icono family of angiography systems.
Xstrahl unveils radiotherapy image-guidance device at ASTRO 2019
September 16, 2019 -- X-ray and radiation therapy technology developer Xstrahl introduced its XSight image-guidance device for radiation therapy at this week's American Society for Radiation Oncology (ASTRO) meeting in Chicago.
Akesis launches new rad therapy systems at ASTRO 2019
September 16, 2019 -- CHICAGO - Radiation therapy developer Akesis is launching two new radiation therapy systems at this week's American Society for Radiation Oncology (ASTRO) meeting.
Elekta secures 5-year Premier contract
September 16, 2019 -- Radiation oncology vendor Elekta has won a five-year, sole-source purchasing agreement for its radiation oncology products and services with group purchasing organization Premier
Zebra partners with Medsynaptic for AI in India
September 16, 2019 -- Artificial intelligence (AI) software developer Zebra Medical Vision has signed a partnership with PACS and teleradiology software developer Medsynaptic of India.
Varian invests in digital health firm Oncora
September 13, 2019 -- Radiation therapy firm Varian Medical Systems has made an investment in Oncora Medical, a developer of software for the management of cancer patients.
Varian: China tariffs lifted from linear accelerators
September 13, 2019 -- The Chinese government has decided to retroactively lift tariffs that were imposed on linear accelerators as part of the trade war between that country and the U.S., according to a statement by radiation oncology firm Varian Medical Systems.
More Mo-99 production woes at ANSTO
September 13, 2019 -- A mechanical problem at the Australian Nuclear Science and Technology Organisation's (ANSTO) Lucas Heights nuclear medicine facility has again forced the medical isotope maker to curtail production.
FDA releases final guidance for special 510(k) process
September 12, 2019 -- The U.S. Food and Drug Administration (FDA) has released a final guidance on its Special 510(k) program.
Cancer survival improves, but at varying rates
September 12, 2019 -- Cancer survival rates for esophagus, stomach, colon, rectum, pancreas, lung, and ovary cancers have improved at varying degrees over the last 20 years in seven high-income countries with universal healthcare, according to research published online September 11 in the Lancet Oncology journal.